Hero image with Pittsburgh background https://pittplusme.org/study/driveteen

STUDY BASICS

Does your child identify as LGBTQ+ and feel sad or like nothing is fun? Your child may be eligible for a research study on how depression develops, and the risk and preventive factors for young people who identify as LBGTQ+. Compensation is provided.


STUDY PURPOSE

This research study is trying to understand the way depression develops in young adults. Depression and a symptom called anhedonia, which involves difficulty with motivation, energy, and anticipation of pleasant events, are related to disruptions in positive emotions and could be based on alterations in the brain’s dopamine system and reward circuitry. They want to understand depression early in life so that they can find ways to help young people develop along healthy pathways and avoid chronic illness.


COULD THIS STUDY BE RIGHT FOR YOUR CHILD?
  • 16-17 years of age
  • Identifying as LGBTQ+
  • People who are currently experiencing depression

WHAT PARTICIPANTS CAN EXPECT
  • 1 In-person visit (Interview, MRI scan, blood draw, and questionnaires) 
  • 1 Virtual 6-Month follow up

IRB: STUDY22060139F
- Depression, Reward, Inflammation, Verve, and Emotion (DRIVE) Study


PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/driveteen and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe

MEET THE RESEARCHER


Erika Forbes

Erika E. Forbes, PhD, is associate professor of psychiatry, psychology, and pediatrics at the University of Pittsburgh. Dr. Forbes is a specialist in the field of depression, especially regarding reward-related brain functioning in adolescents. Her research has been published in a number of leading publications. She has received awards and honors from the University of Pittsburgh, American College of Neuropsychopharmacology, National Alliance for Research on Schizophrenia and Depression, and the National Institute of Health.